Merck’s $53‑per‑share Deal Triggers Cash Payout for Terns Director’s Options

*TL;DR Merck will pay $53 per Terns share, cancelling any unexercised options below that price; director David A. Fellows surrendered nine such options, receiving cash for the spread.*

Context Merck Sharp & Dohme LLC agreed to acquire Terns Pharmaceuticals in an all‑cash transaction. The merger consideration is set at $53 for each Terns share, payable at the deal’s closing. Under the merger agreement, any outstanding stock options with exercise prices lower than $53 are automatically cancelled and converted into a cash right equal to the difference between $53 and the option’s strike price.

Key Facts - The merger price is $53 per share, a fixed cash amount rather than stock or mixed consideration. - Terns director David A. Fellows held nine option awards with exercise prices ranging from $1.82 to $34.60. - At the effective time of the merger, all nine unexercised options were cancelled under the agreement. - The cancellation triggers a cash payment equal to $53 minus each option’s exercise price, subject to withholding taxes. - The Form 4 filing shows the options covered 225,136 underlying shares, but no market price was recorded because the payout is a contractual cash adjustment, not a trade.

What It Means The cash‑only structure simplifies the transaction for shareholders and insiders alike. Fellows’ options, though unexercised, generate a cash benefit because their strike prices sit well below the $53 merger price. This mechanism ensures that option holders receive the full economic value of their grants without needing to purchase shares first.

For Terns investors, the $53 per share offer represents a premium over recent trading levels, effectively converting all equity stakes into cash. The director’s option cash‑out underscores how merger clauses can convert latent equity compensation into immediate liquidity.

Looking Ahead Watch for the final cash distribution figures at the merger’s closing and any subsequent filings that detail the total payout to all option holders.